[go: up one dir, main page]

ES8801917A1 - Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico - Google Patents

Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico

Info

Publication number
ES8801917A1
ES8801917A1 ES557057A ES557057A ES8801917A1 ES 8801917 A1 ES8801917 A1 ES 8801917A1 ES 557057 A ES557057 A ES 557057A ES 557057 A ES557057 A ES 557057A ES 8801917 A1 ES8801917 A1 ES 8801917A1
Authority
ES
Spain
Prior art keywords
amino
general formula
compound
thiazolyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557057A
Other languages
English (en)
Other versions
ES557057A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES8801917A1 publication Critical patent/ES8801917A1/es
Publication of ES557057A0 publication Critical patent/ES557057A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18—Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO ACIDO 3S(Z)-2-1-(2-AMINO-4-TIAZOLIL)-2,2-DIMETIL-4-OXO-1-(SULFOOXI)-3-AZETIDINILAMINO-2-OXOETILIDEN-AMINOOXIACETICO, DE FORMULA GENERAL (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN ACILAR UN COMPUESTO DE FORMULA GENERAL (II) CON UN COMPUESTO DE ACIDO CARBOXILICO DE FORMULA GENERAL (III), EN LAS QUE R ES UN GRUPO PROTECTOR DE ACIDO CARBOXILICO QUE ES POSTERIORMENTE ELIMINADO. EL COMPUESTO DE FORMULA GENERAL (III) ESTA PREFERIBLEMENTE EN FORMA DE UN HALURO DE ACIDO, UN ANHIDRIDO O UN ESTER ACTIVO Y SE LLEVA A CABO LA REACCION PREFERIBLEMENTE EN UN DISOLVENTE ORGANICO INERTE, TAL COMO DIMETILFORMAMIDA, A UNA TEMPERATURA DE APROXIMADAMENTE C30 GRADOS. DE APLICACION EN MEDICINA Y FARMACIA POR SU ACTIVIDAD ANTIBACTERIANA.
ES557057A 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico Expired ES8801917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/695,775 US4638061A (en) 1985-01-28 1985-01-28 [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Publications (2)

Publication Number Publication Date
ES8801917A1 true ES8801917A1 (es) 1988-03-01
ES557057A0 ES557057A0 (es) 1988-03-01

Family

ID=24794413

Family Applications (3)

Application Number Title Priority Date Filing Date
ES551252A Expired ES8706112A1 (es) 1985-01-28 1986-01-27 Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ES557056A Expired ES8800897A1 (es) 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto 3(s)-3-amino-2-oxo-4,4-dimetil-1-azetidinilsulfato
ES557057A Expired ES8801917A1 (es) 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES551252A Expired ES8706112A1 (es) 1985-01-28 1986-01-27 Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ES557056A Expired ES8800897A1 (es) 1985-01-28 1986-09-09 Un procedimiento para preparar el compuesto 3(s)-3-amino-2-oxo-4,4-dimetil-1-azetidinilsulfato

Country Status (35)

Country Link
US (1) US4638061A (es)
JP (2) JPH0780840B2 (es)
KR (1) KR900000675B1 (es)
CN (1) CN1014894B (es)
AR (1) AR242024A1 (es)
AT (1) AT389511B (es)
AU (1) AU588017B2 (es)
BE (1) BE904121A (es)
CA (2) CA1283924C (es)
CH (3) CH670825A5 (es)
CS (1) CS253740B2 (es)
DD (3) DD248592A5 (es)
DE (1) DE3602347A1 (es)
DK (1) DK39486A (es)
EG (1) EG17682A (es)
ES (3) ES8706112A1 (es)
FI (1) FI85022C (es)
FR (1) FR2576596B1 (es)
GB (2) GB2170201B (es)
GR (1) GR860239B (es)
HU (1) HU196367B (es)
IE (2) IE59629B1 (es)
IL (1) IL77661A (es)
IT (1) IT1190604B (es)
LU (1) LU86262A1 (es)
NL (1) NL8600136A (es)
NO (1) NO170014C (es)
NZ (1) NZ214836A (es)
PH (3) PH22425A (es)
PL (3) PL257668A1 (es)
PT (1) PT81914B (es)
RO (1) RO93483B (es)
SE (3) SE467824B (es)
YU (2) YU45760B (es)
ZA (1) ZA86302B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751220A (en) * 1986-12-19 1988-06-14 E. R. Squibb & Sons, Inc. Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
EP0336667A3 (en) * 1988-04-04 1991-04-10 E.R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
US4973747A (en) * 1989-08-15 1990-11-27 E. R. Squibb & Sons, Inc. Process for preparing 3-hydroxy 2-keto acids
US8901293B2 (en) * 2005-12-07 2014-12-02 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2017180794A1 (en) 2016-04-13 2017-10-19 Skyline Antiinfectives, Inc. Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) * 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規２−アゼチジノン誘導体
JPS58206589A (ja) * 1982-05-26 1983-12-01 Yamanouchi Pharmaceut Co Ltd ２−アゼチジノン誘導体
US4565654A (en) * 1983-03-28 1986-01-21 University Of Notre Dame Du Lac N-Acyloxy monocyclic β-lactams

Also Published As

Publication number Publication date
YU45760B (sh) 1992-07-20
KR860005812A (ko) 1986-08-13
AU588017B2 (en) 1989-09-07
GR860239B (en) 1986-05-28
ATA20386A (de) 1989-05-15
YU5886A (en) 1988-02-29
HU196367B (en) 1988-11-28
PH23084A (en) 1989-04-10
CS253740B2 (en) 1987-12-17
LU86262A1 (fr) 1986-08-04
CA1283924C (en) 1991-05-07
FR2576596A1 (fr) 1986-08-01
GB2198133B (en) 1989-01-11
IL77661A (en) 1989-06-30
SE9002338D0 (sv) 1990-07-03
AR242024A1 (es) 1993-02-26
YU167087A (en) 1988-04-30
JPH0780840B2 (ja) 1995-08-30
ES557056A0 (es) 1987-12-01
DK39486A (da) 1986-07-29
SE467824B (sv) 1992-09-21
NZ214836A (en) 1988-10-28
CA1279322C (en) 1991-01-22
SE8600355L (sv) 1986-07-29
PL262317A1 (en) 1987-09-07
RO93483B (ro) 1988-01-01
CN1014894B (zh) 1991-11-27
US4638061A (en) 1987-01-20
SE9002338L (sv) 1990-07-03
EG17682A (en) 1990-10-30
RO93483A (ro) 1987-12-31
IE860205L (en) 1986-07-28
GB8800425D0 (en) 1988-02-10
IT8619206A0 (it) 1986-01-28
ES557057A0 (es) 1988-03-01
DE3602347A1 (de) 1986-07-31
BE904121A (fr) 1986-05-15
AU5246086A (en) 1986-07-31
CN86100736A (zh) 1986-10-22
FI85022C (fi) 1992-02-25
NO170014C (no) 1992-09-02
AT389511B (de) 1989-12-27
GB2170201B (en) 1989-01-11
CH667872A5 (fr) 1988-11-15
NO860273L (no) 1986-07-29
IT1190604B (it) 1988-02-16
FR2576596B1 (fr) 1989-12-15
ES551252A0 (es) 1987-06-01
ES8800897A1 (es) 1987-12-01
CH670824A5 (es) 1989-07-14
IE59629B1 (en) 1994-03-09
SE9002337D0 (sv) 1990-07-03
IE930750L (en) 1986-07-28
JPS61176563A (ja) 1986-08-08
SE468896B (sv) 1993-04-05
FI860247L (fi) 1986-07-29
PT81914A (en) 1986-02-01
SE502442C2 (sv) 1995-10-16
KR900000675B1 (ko) 1990-02-02
PL257668A1 (en) 1987-03-09
HUT40407A (en) 1986-12-28
DD248584A5 (de) 1987-08-12
ZA86302B (en) 1986-08-27
SE8600355D0 (sv) 1986-01-27
PL262318A1 (en) 1987-09-07
SE9002337L (sv) 1990-07-03
NL8600136A (nl) 1986-08-18
PH22425A (en) 1988-09-12
CH670825A5 (es) 1989-07-14
PH23093A (en) 1989-04-10
GB2198133A (en) 1988-06-08
GB2170201A (en) 1986-07-30
NO170014B (no) 1992-05-25
ES8706112A1 (es) 1987-06-01
FI85022B (fi) 1991-11-15
DD241600A5 (de) 1986-12-17
FI860247A0 (fi) 1986-01-20
DK39486D0 (da) 1986-01-27
PT81914B (pt) 1987-11-30
JPH0853404A (ja) 1996-02-27
DD248592A5 (de) 1987-08-12
PL149156B1 (en) 1990-01-31

Similar Documents

Publication Publication Date Title
AR017164A1 (es) Derivados de la benzamidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, los medicamentos y laspreparaciones farmaceuticas que contienen estos derivados de la benzamidina, y un procedimiento para obtener estas preparaciones farmaceuticas.
ES2057604T3 (es) Enantiomero r de n-propargil-1-aminoindano, su preparacion y composiciones farmaceuticas que lo contienen.
HUP0004423A2 (hu) Acil-szulfamoil-benzoesav-amidok, az ezeket tartalmazó haszonnövényvédő készítmények és eljárás az előállításukra
IT1256345B (it) Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
ES2167720T3 (es) Compuestos de 1-fenilpirazol y aplicaciones medicinales de los mismos.
CR5826A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion
NO982500L (no) FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet, samt forbindelsen dihydratet derav som sÕdan
MX9303441A (es) Procedimiento para la preparacion de acido clavulanico.
ES8801917A1 (es) Un procedimiento para preparar el compuesto acido (3s(z))7-2-(1-(2-amino-4-tiazolil)-2-(2,2-dimetil-4-oxo-1(sulfooxi)-3-azetidinil)amino)-2-oxoetiliden)amino)oxi)acetico
AR013967A1 (es) UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE
NO164166C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoletanolestere.
FI890722A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 7-/2-(2-aminotiatsol-4-yyli)-2-(Z)-hydroksi-iminoasetamido/-3-(metoksimetyyli)-3-kefeemi-4-karboksyylihappo-/ -(2,2-dimetyylipropionyylioksi)etyyli/esterin diastereomeerin I valmistamiseksi
EA199900812A1 (ru) Производные циклопентенона
DK0571243T3 (da) Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse
CO4950549A1 (es) Procedimiento
ITMI930337A0 (it) Esteri di acidi carbossilici di idrossifenilelcanoli come agenti stabilizzanti
PT83667B (pt) Processo para a preparacao de acidos e esteres {{{(3-piridinil)metileno}amino}oxi}-alcanoicos e de composicoes farmaceuticas que os contenham
ES8703423A1 (es) Un procedimiento para producir un derivado de acido indola- cetico
ES8603492A1 (es) Un metodo para la preparacion de nuevos derivados penem
SE8802066L (sv) N-imidazolyl derivater av bicykliska foereningar anvaendbara inom medicin
ES8801205A1 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
FI935712L (fi) Menetelmä optisesti aktiivisten transglysidihappoestereiden entsyaattiseksi valmistamiseksi
ES8704495A1 (es) Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.
ITMI920560A0 (it) Procedimento per la preparazione di acido iodesossicolico ad elevata purezza per impiego farmaceutico
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102